Literature DB >> 10618375

The crystal structure of modified bovine fibrinogen.

J H Brown1, N Volkmann, G Jun, A H Henschen-Edman, C Cohen.   

Abstract

Here we report the crystal structure at approximately 4-A resolution of a selectively proteolyzed bovine fibrinogen. This key component in hemostasis is an elongated 340-kDa glycoprotein in the plasma that upon activation by thrombin self-assembles to form the fibrin clot. The crystals are unusual because they are made up of end-to-end bonded molecules that form flexible filaments. We have visualized the entire coiled-coil region of the molecule, which has a planar sigmoidal shape. The primary polymerization receptor pockets at the ends of the molecule face the same way throughout the end-to-end bonded filaments, and based on this conformation, we have developed an improved model of the two-stranded protofibril that is the basic building block in fibrin. Near the middle of the coiled-coil region, the plasmin-sensitive segment is a hinge about which the molecule adopts different conformations. This segment also includes the boundary between the three- and four-stranded portions of the coiled coil, indicating the location on the backbone that anchors the extended flexible Aalpha arm. We suggest that a flexible branch point in the molecule may help accommodate variability in the structure of the fibrin clot.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618375      PMCID: PMC26620          DOI: 10.1073/pnas.97.1.85

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Axial period of fibrinogen and fibrin.

Authors:  L STRYER; C COHEN; R LANGRIDGE
Journal:  Nature       Date:  1963-02-23       Impact factor: 49.962

2.  The amino acid sequence of the alpha-chain of human fibrinogen.

Authors:  R F Doolittle; K W Watt; B A Cottrell; D D Strong; M Riley
Journal:  Nature       Date:  1979-08-09       Impact factor: 49.962

3.  Amino acid sequence of human fibrin. Preliminary note on the completion of the intermediate part of the alpha-chain sequence.

Authors:  A Henschen; F Lottspeich; B Hessel
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-12

4.  Crystalline states of a modified fibrinogen.

Authors:  N M Tooney; C Cohen
Journal:  J Mol Biol       Date:  1977-02-25       Impact factor: 5.469

5.  Structural organization of C-terminal parts of fibrinogen A alpha-chains.

Authors:  L V Medved; O V Gorkun; P L Privalov
Journal:  FEBS Lett       Date:  1983-08-22       Impact factor: 4.124

6.  Identification and mass analysis of human fibrinogen molecules and their domains by scanning transmission electron microscopy.

Authors:  M W Mosesson; J Hainfeld; J Wall; R H Haschemeyer
Journal:  J Mol Biol       Date:  1981-12-15       Impact factor: 5.469

7.  Crystals of modified fibrinogen: size, shape and packing of molecules.

Authors:  J W Weisel; S G Warren; C Cohen
Journal:  J Mol Biol       Date:  1978-12-05       Impact factor: 5.469

8.  A model from electron microscopy for the molecular structure of fibrinogen and fibrin.

Authors:  J W Weisel; G N Phillips; C Cohen
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

9.  Assembly of fibrin. A light scattering study.

Authors:  R R Hantgan; J Hermans
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

10.  The structure of fibrinogen and fibrin: II. Architecture of the fibrin clot.

Authors:  J W Weisel; G N Phillips; C Cohen
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

View more
  41 in total

1.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides.

Authors:  Z Yang; I Mochalkin; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Crystal structure of native chicken fibrinogen at 5.5-A resolution.

Authors:  Z Yang; I Mochalkin; L Veerapandian; M Riley; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

3.  Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-A resolution.

Authors:  J Madrazo; J H Brown; S Litvinovich; R Dominguez; S Yakovlev; L Medved; C Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

4.  Mechanism of fibrin(ogen) forced unfolding.

Authors:  Artem Zhmurov; Andre E X Brown; Rustem I Litvinov; Ruxandra I Dima; John W Weisel; Valeri Barsegov
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

5.  Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3.

Authors:  M Guthold; W Liu; B Stephens; S T Lord; R R Hantgan; D A Erie; R M Taylor; R Superfine
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

Review 6.  Breaking symmetry in protein dimers: designs and functions.

Authors:  Jerry H Brown
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

7.  The elasticity of an individual fibrin fiber in a clot.

Authors:  Jean-Philippe Collet; Henry Shuman; Robert E Ledger; Seungtaek Lee; John W Weisel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

Review 8.  A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers.

Authors:  M Guthold; W Liu; E A Sparks; L M Jawerth; L Peng; M Falvo; R Superfine; R R Hantgan; S T Lord
Journal:  Cell Biochem Biophys       Date:  2007-10-02       Impact factor: 2.194

9.  Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.

Authors:  Igor Pechik; Sergiy Yakovlev; Michael W Mosesson; Gary L Gilliland; Leonid Medved
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

10.  Structural Basis of Interfacial Flexibility in Fibrin Oligomers.

Authors:  Artem Zhmurov; Anna D Protopopova; Rustem I Litvinov; Pavel Zhukov; Alexander R Mukhitov; John W Weisel; Valeri Barsegov
Journal:  Structure       Date:  2016-09-29       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.